Fedenia Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Fedenia Advisers's ABBV Position: Q3 2026 in Review
Fedenia Advisers sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 548 shares — an estimated $138K sold.
Fedenia Advisers first reported a position in ABBV in Q4 2024 and held it in 2 quarters. The position peaked at $138K in Q2 2026. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Fedenia Advisers reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
- Fedenia Advisers sold 548 AbbVie shares in Q3 2026, an estimated $138K.
- Fedenia Advisers first reported a position in AbbVie in Q4 2024 and held it in 2 quarters.
- Fedenia Advisers's AbbVie position peaked at $138K in Q2 2026.
- 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Fedenia Advisers's 13F filing for Q3 2026, filed 22 Oct 2026.